Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
NCT07125183Phase 2Recruiting
- Sponsor
- University of Colorado Denver
- Start
- Dec 2026
- Primary completion
- Dec 2028
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin in leiomyosarcoma (LMS), sponsored by University of Colorado Denver. Planned start Dec 2026; status: recruiting.
02
Drugs
doxorubicin
03
Conditions
leiomyosarcoma (LMS)
Beyond the preview
Go deeper on NCT07125183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07125183.